Data Foundry

Drug recalls 2024

B-Complex — Class II drug recall D-0203-2024

Terminated recall by AnazaoHealth Corporation, reported 2024-01-03, distributed nationwide. Presence of Particulate Matter.

Recall numberD-0203-2024
Product typeDrug
ClassificationClass II
StatusTerminated
Voluntary or mandatedVoluntary
Recalling firmAnazaoHealth Corporation, Las Vegas, NV, United States
Recall initiated2023-11-22
Classified2023-12-26
Reported by FDA2024-01-03
Terminated2025-09-29
DistributedNationwide (US)
Quantity5,707 vials
Reason classesspecification failure
NDC72682-2230-03
Lot numbers505075, 505596, 506155, 508103, 510837, 512411, 514856, 515642, 518309, 524262, 524266, 524909, 526526, 529204, 530858, 535766
Expiration dates2024-02-05, 2024-02-06, 2024-02-07, 2024-02-13, 2024-02-19, 2024-02-20, 2024-02-25, 2024-02-28, 2024-03-05, 2024-03-12, 2024-03-13, 2024-03-16, 2024-03-18, 2024-03-20, 2024-03-30

Product

B-Complex, Thiamine HCI / Riboflavin / Niacinamide / Dexpanthenol / Pyridoxine HCI injection, 74/2/75/2/2 MG/ML, 30ML Sterile Multiple-Dose Vial, Rx only, AnazaoHealth, 7465 W Sunset Rd #1200, Las Vegas, NV 89113, NDC 72682-2230-3

Reason for recall

Presence of Particulate Matter.

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0203-2024. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.